Science and engineering

the IONA® test to be offered in the Center for Medical Genomics, Ramathibodi Hospital partnering with the Thailand Center of Excellence for Life Sciences (TCELS) 

November 17th saw the opening of the world unique research program Smart Energy City in Stockholm, Sweden.

New funding for vaccine development projects to help fight deadly diseases like Zika and Ebola.

ALROSA, the world leader in diamond mining, is launching satellite radar monitoring of the earth surface displacement in the areas of its diamond deposits.

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, reported financial results and provided corporate and clinical developments for the first quarter of fiscal year 2017, ended September 30, 2016.

Seasonally adjusted GDP rose by 0.3% in the euro area (EA19) and by 0.4% in the EU28 during the third quarter of 2016, compared with the previous quarter, according to a flash estimate published by Eurostat, the statistical office of the European Union. 

The expected duration of working life in the European Union (EU) stood at 35.4 years on average in 2015, up by 1.9 years compared with 2005. 

Verseon will present new preclinical data on its novel class of oral anticoagulants at the American Heart Association's Scientific Sessions in New Orleans on November 15.

Purpose of the partnership is to research the potential uses of artificial intelligence in future applications such as automated driving Frankfurt (Germany)/Oxford (United Kingdom), November 11, 2016. 

Bristol-Myers Squibb Company (NYSE: BMY) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo in combination with Infinity’s IPI-549 in patients with advanced solid tumors.

A Yale professor’s five-year quest to re-establish a tradition of rigorous scholarship and research in Myanmar (formerly Burma) has come to fulfillment with the publication of the first issue of the Independent Journal of Burmese Scholarship.

Early farmers pushed dog genomes toward vegetarianism

Avacta Group plc (AIM: AVCT), the developer of Affimer^® biotherapeutics and research reagents, today announced it has appointed Professor Gerard Evan, FRS, to its therapeutics Scientific Advisory Board.